Ontario Uro-Oncologist to lead Canadian group of kidney cancer experts
July 29, 2015
Kidney Cancer Canada is pleased to announce leading researcher and Uro-Oncologist, Dr. Anil Kapoor, as the new Chair of its Medical Advisory Board.
As the Director of the McMaster Institute of Urology at St. Joseph’s Healthcare Hamilton, Dr. Kapoor knows first-hand the importance of providing patients with the most current advances in kidney cancer treatment.
Dr. Kapoor takes over from outgoing Chair Dr. Lori Wood. “It is an honour to succeed Dr. Wood as Chair this progressive and knowledgeable group of clinicians”, says Kapoor. “We support Kidney Cancer Canada as a vital source of information and support for patients and caregivers”.
ABOUT DR. KAPOOR
Dr. Anil Kapoor is a leading researcher and clinician in the fields of kidney cancer and prostate cancer. He serves as the Head, Genito-Urinary Oncology Program at the Juravinski Cancer Centre at McMaster University and is an affiliated researcher of the Research Institute of St. Joseph’s Healthcare Hamilton.
Kapoor is entering his eighth year as a member of the Kidney Cancer Canada Medical Advisory Board and represents the Kidney Cancer Research Network of Canada. He is also Chair of the Kidney Cancer Disease Site committee of the National Cancer Institute of Canada Clinical Trials Group and the Canadian Urologic Oncology Group. A photo of Dr. Kapoor is available here.
ABOUT THE KIDNEY CANCER MEDICAL ADVISORY BOARD
The Medical Advisory Board plays a critical role for Kidney Cancer Canada, providing oversight for health information, identifying treatment issues, and promoting the patient driven organization as an essential resource to its colleagues across Canada. A full list of the board is available here.
ABOUT KIDNEY CANCER CANADA
More than 24,000 Canadians are living with a diagnosis of kidney cancer. Kidney Cancer Canada is the only national Canadian health charity dedicated to improving the lives of those affected by kidney cancer. www.KidneyCancerCanada.ca
For more information and interviews contact:
Kidney Cancer Canada